1 Novel Drug Reconstitution System Market Overview 1.1 Product Overview and Scope of Novel Drug Reconstitution System 1.2 Novel Drug Reconstitution System Segment by Type 1.2.1 Global Novel Drug Reconstitution System Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Bottled 1.2.3 Bagged 1.3 Novel Drug Reconstitution System Segment by Application 1.3.1 Global Novel Drug Reconstitution System Sales Comparison by Application: (2022-2028) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Global Novel Drug Reconstitution System Market Size Estimates and Forecasts 1.4.1 Global Novel Drug Reconstitution System Revenue 2017-2028 1.4.2 Global Novel Drug Reconstitution System Sales 2017-2028 1.4.3 Novel Drug Reconstitution System Market Size by Region: 2017 Versus 2021 Versus 2028 2 Novel Drug Reconstitution System Market Competition by Manufacturers 2.1 Global Novel Drug Reconstitution System Sales Market Share by Manufacturers (2017-2022) 2.2 Global Novel Drug Reconstitution System Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Novel Drug Reconstitution System Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Novel Drug Reconstitution System Manufacturing Sites, Area Served, Product Type 2.5 Novel Drug Reconstitution System Market Competitive Situation and Trends 2.5.1 Novel Drug Reconstitution System Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Novel Drug Reconstitution System Players Market Share by Revenue 2.5.3 Global Novel Drug Reconstitution System Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Novel Drug Reconstitution System Retrospective Market Scenario by Region 3.1 Global Novel Drug Reconstitution System Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Novel Drug Reconstitution System Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Novel Drug Reconstitution System Market Facts & Figures by Country 3.3.1 North America Novel Drug Reconstitution System Sales by Country 3.3.2 North America Novel Drug Reconstitution System Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Novel Drug Reconstitution System Market Facts & Figures by Country 3.4.1 Europe Novel Drug Reconstitution System Sales by Country 3.4.2 Europe Novel Drug Reconstitution System Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Novel Drug Reconstitution System Market Facts & Figures by Region 3.5.1 Asia Pacific Novel Drug Reconstitution System Sales by Region 3.5.2 Asia Pacific Novel Drug Reconstitution System Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Novel Drug Reconstitution System Market Facts & Figures by Country 3.6.1 Latin America Novel Drug Reconstitution System Sales by Country 3.6.2 Latin America Novel Drug Reconstitution System Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.6.6 Colombia 3.7 Middle East and Africa Novel Drug Reconstitution System Market Facts & Figures by Country 3.7.1 Middle East and Africa Novel Drug Reconstitution System Sales by Country 3.7.2 Middle East and Africa Novel Drug Reconstitution System Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Novel Drug Reconstitution System Historic Market Analysis by Type 4.1 Global Novel Drug Reconstitution System Sales Market Share by Type (2017-2022) 4.2 Global Novel Drug Reconstitution System Revenue Market Share by Type (2017-2022) 4.3 Global Novel Drug Reconstitution System Price by Type (2017-2022) 5 Global Novel Drug Reconstitution System Historic Market Analysis by Application 5.1 Global Novel Drug Reconstitution System Sales Market Share by Application (2017-2022) 5.2 Global Novel Drug Reconstitution System Revenue Market Share by Application (2017-2022) 5.3 Global Novel Drug Reconstitution System Price by Application (2017-2022) 6 Key Companies Profiled 6.1 3M Innovative Properties 6.1.1 3M Innovative Properties Corporation Information 6.1.2 3M Innovative Properties Description and Business Overview 6.1.3 3M Innovative Properties Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.1.4 3M Innovative Properties Novel Drug Reconstitution System Product Portfolio 6.1.5 3M Innovative Properties Recent Developments/Updates 6.2 Baxter 6.2.1 Baxter Corporation Information 6.2.2 Baxter Description and Business Overview 6.2.3 Baxter Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Baxter Novel Drug Reconstitution System Product Portfolio 6.2.5 Baxter Recent Developments/Updates 6.3 JW Group 6.3.1 JW Group Corporation Information 6.3.2 JW Group Description and Business Overview 6.3.3 JW Group Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.3.4 JW Group Novel Drug Reconstitution System Product Portfolio 6.3.5 JW Group Recent Developments/Updates 6.4 Pfizer 6.4.1 Pfizer Corporation Information 6.4.2 Pfizer Description and Business Overview 6.4.3 Pfizer Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Pfizer Novel Drug Reconstitution System Product Portfolio 6.4.5 Pfizer Recent Developments/Updates 6.5 Takeda 6.5.1 Takeda Corporation Information 6.5.2 Takeda Description and Business Overview 6.5.3 Takeda Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Takeda Novel Drug Reconstitution System Product Portfolio 6.5.5 Takeda Recent Developments/Updates 6.6 Aerie Pharmaceuticals 6.6.1 Aerie Pharmaceuticals Corporation Information 6.6.2 Aerie Pharmaceuticals Description and Business Overview 6.6.3 Aerie Pharmaceuticals Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Aerie Pharmaceuticals Novel Drug Reconstitution System Product Portfolio 6.6.5 Aerie Pharmaceuticals Recent Developments/Updates 6.7 Ionis Pharmaceuticals 6.6.1 Ionis Pharmaceuticals Corporation Information 6.6.2 Ionis Pharmaceuticals Description and Business Overview 6.6.3 Ionis Pharmaceuticals Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Ionis Pharmaceuticals Novel Drug Reconstitution System Product Portfolio 6.7.5 Ionis Pharmaceuticals Recent Developments/Updates 6.8 Eisai 6.8.1 Eisai Corporation Information 6.8.2 Eisai Description and Business Overview 6.8.3 Eisai Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Eisai Novel Drug Reconstitution System Product Portfolio 6.8.5 Eisai Recent Developments/Updates 6.9 Covis Pharma 6.9.1 Covis Pharma Corporation Information 6.9.2 Covis Pharma Description and Business Overview 6.9.3 Covis Pharma Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Covis Pharma Novel Drug Reconstitution System Product Portfolio 6.9.5 Covis Pharma Recent Developments/Updates 6.10 Allergan 6.10.1 Allergan Corporation Information 6.10.2 Allergan Description and Business Overview 6.10.3 Allergan Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Allergan Novel Drug Reconstitution System Product Portfolio 6.10.5 Allergan Recent Developments/Updates 6.11 Gilead Sciences 6.11.1 Gilead Sciences Corporation Information 6.11.2 Gilead Sciences Novel Drug Reconstitution System Description and Business Overview 6.11.3 Gilead Sciences Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Gilead Sciences Novel Drug Reconstitution System Product Portfolio 6.11.5 Gilead Sciences Recent Developments/Updates 6.12 Bayer Healthcare 6.12.1 Bayer Healthcare Corporation Information 6.12.2 Bayer Healthcare Novel Drug Reconstitution System Description and Business Overview 6.12.3 Bayer Healthcare Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Bayer Healthcare Novel Drug Reconstitution System Product Portfolio 6.12.5 Bayer Healthcare Recent Developments/Updates 6.13 Credence Medsystems 6.13.1 Credence Medsystems Corporation Information 6.13.2 Credence Medsystems Novel Drug Reconstitution System Description and Business Overview 6.13.3 Credence Medsystems Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.13.4 Credence Medsystems Novel Drug Reconstitution System Product Portfolio 6.13.5 Credence Medsystems Recent Developments/Updates 6.14 Amgen 6.14.1 Amgen Corporation Information 6.14.2 Amgen Novel Drug Reconstitution System Description and Business Overview 6.14.3 Amgen Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.14.4 Amgen Novel Drug Reconstitution System Product Portfolio 6.14.5 Amgen Recent Developments/Updates 6.15 Roche 6.15.1 Roche Corporation Information 6.15.2 Roche Novel Drug Reconstitution System Description and Business Overview 6.15.3 Roche Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.15.4 Roche Novel Drug Reconstitution System Product Portfolio 6.15.5 Roche Recent Developments/Updates 6.16 GlaxoSmithKline 6.16.1 GlaxoSmithKline Corporation Information 6.16.2 GlaxoSmithKline Novel Drug Reconstitution System Description and Business Overview 6.16.3 GlaxoSmithKline Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.16.4 GlaxoSmithKline Novel Drug Reconstitution System Product Portfolio 6.16.5 GlaxoSmithKline Recent Developments/Updates 6.17 Vertex Pharmaceuticals 6.17.1 Vertex Pharmaceuticals Corporation Information 6.17.2 Vertex Pharmaceuticals Novel Drug Reconstitution System Description and Business Overview 6.17.3 Vertex Pharmaceuticals Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.17.4 Vertex Pharmaceuticals Novel Drug Reconstitution System Product Portfolio 6.17.5 Vertex Pharmaceuticals Recent Developments/Updates 6.18 Synergy Pharmaceuticals 6.18.1 Synergy Pharmaceuticals Corporation Information 6.18.2 Synergy Pharmaceuticals Novel Drug Reconstitution System Description and Business Overview 6.18.3 Synergy Pharmaceuticals Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.18.4 Synergy Pharmaceuticals Novel Drug Reconstitution System Product Portfolio 6.18.5 Synergy Pharmaceuticals Recent Developments/Updates 6.19 Otsuka Pharmaceutical 6.19.1 Otsuka Pharmaceutical Corporation Information 6.19.2 Otsuka Pharmaceutical Novel Drug Reconstitution System Description and Business Overview 6.19.3 Otsuka Pharmaceutical Novel Drug Reconstitution System Sales, Revenue and Gross Margin (2017-2022) 6.19.4 Otsuka Pharmaceutical Novel Drug Reconstitution System Product Portfolio 6.19.5 Otsuka Pharmaceutical Recent Developments/Updates 7 Novel Drug Reconstitution System Manufacturing Cost Analysis 7.1 Novel Drug Reconstitution System Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Novel Drug Reconstitution System 7.4 Novel Drug Reconstitution System Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Novel Drug Reconstitution System Distributors List 8.3 Novel Drug Reconstitution System Customers 9 Novel Drug Reconstitution System Market Dynamics 9.1 Novel Drug Reconstitution System Industry Trends 9.2 Novel Drug Reconstitution System Market Drivers 9.3 Novel Drug Reconstitution System Market Challenges 9.4 Novel Drug Reconstitution System Market Restraints 10 Global Market Forecast 10.1 Novel Drug Reconstitution System Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Novel Drug Reconstitution System by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Novel Drug Reconstitution System by Type (2023-2028) 10.2 Novel Drug Reconstitution System Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Novel Drug Reconstitution System by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Novel Drug Reconstitution System by Application (2023-2028) 10.3 Novel Drug Reconstitution System Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Novel Drug Reconstitution System by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Novel Drug Reconstitution System by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Novel Drug Reconstitution System Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Novel Drug Reconstitution System Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Novel Drug Reconstitution System Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Novel Drug Reconstitution System Market Competitive Situation by Manufacturers in 2021 Table 5. Global Novel Drug Reconstitution System Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Novel Drug Reconstitution System Sales Market Share by Manufacturers (2017-2022) Table 7. Global Novel Drug Reconstitution System Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Novel Drug Reconstitution System Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Novel Drug Reconstitution System Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Novel Drug Reconstitution System Manufacturing Sites and Area Served Table 11. Manufacturers Novel Drug Reconstitution System Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Novel Drug Reconstitution System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Reconstitution System as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Novel Drug Reconstitution System Sales by Region (2017-2022) & (K Units) Table 16. Global Novel Drug Reconstitution System Sales Market Share by Region (2017-2022) Table 17. Global Novel Drug Reconstitution System Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Novel Drug Reconstitution System Revenue Market Share by Region (2017-2022) Table 19. North America Novel Drug Reconstitution System Sales by Country (2017-2022) & (K Units) Table 20. North America Novel Drug Reconstitution System Sales Market Share by Country (2017-2022) Table 21. North America Novel Drug Reconstitution System Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Novel Drug Reconstitution System Revenue Market Share by Country (2017-2022) Table 23. Europe Novel Drug Reconstitution System Sales by Country (2017-2022) & (K Units) Table 24. Europe Novel Drug Reconstitution System Sales Market Share by Country (2017-2022) Table 25. Europe Novel Drug Reconstitution System Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Novel Drug Reconstitution System Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Novel Drug Reconstitution System Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Novel Drug Reconstitution System Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Novel Drug Reconstitution System Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Novel Drug Reconstitution System Revenue Market Share by Region (2017-2022) Table 31. Latin America Novel Drug Reconstitution System Sales by Country (2017-2022) & (K Units) Table 32. Latin America Novel Drug Reconstitution System Sales Market Share by Country (2017-2022) Table 33. Latin America Novel Drug Reconstitution System Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Novel Drug Reconstitution System Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Novel Drug Reconstitution System Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Novel Drug Reconstitution System Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Novel Drug Reconstitution System Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Novel Drug Reconstitution System Revenue Market Share by Country (2017-2022) Table 39. Global Novel Drug Reconstitution System Sales by Type (2017-2022) & (K Units) Table 40. Global Novel Drug Reconstitution System Sales Market Share by Type (2017-2022) Table 41. Global Novel Drug Reconstitution System Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Novel Drug Reconstitution System Revenue Share by Type (2017-2022) Table 43. Global Novel Drug Reconstitution System Price by Type (2017-2022) & (US$/Unit) Table 44. Global Novel Drug Reconstitution System Sales (K Units) by Application (2017-2022) Table 45. Global Novel Drug Reconstitution System Sales Market Share by Application (2017-2022) Table 46. Global Novel Drug Reconstitution System Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Novel Drug Reconstitution System Revenue Share by Application (2017-2022) Table 48. Global Novel Drug Reconstitution System Price by Application (2017-2022) & (US$/Unit) Table 49. 3M Innovative Properties Corporation Information Table 50. 3M Innovative Properties Description and Business Overview Table 51. 3M Innovative Properties Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. 3M Innovative Properties Novel Drug Reconstitution System Product Table 53. 3M Innovative Properties Recent Developments/Updates Table 54. Baxter Corporation Information Table 55. Baxter Description and Business Overview Table 56. Baxter Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Baxter Novel Drug Reconstitution System Product Table 58. Baxter Recent Developments/Updates Table 59. JW Group Corporation Information Table 60. JW Group Description and Business Overview Table 61. JW Group Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. JW Group Novel Drug Reconstitution System Product Table 63. JW Group Recent Developments/Updates Table 64. Pfizer Corporation Information Table 65. Pfizer Description and Business Overview Table 66. Pfizer Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Pfizer Novel Drug Reconstitution System Product Table 68. Pfizer Recent Developments/Updates Table 69. Takeda Corporation Information Table 70. Takeda Description and Business Overview Table 71. Takeda Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Takeda Novel Drug Reconstitution System Product Table 73. Takeda Recent Developments/Updates Table 74. Aerie Pharmaceuticals Corporation Information Table 75. Aerie Pharmaceuticals Description and Business Overview Table 76. Aerie Pharmaceuticals Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. Aerie Pharmaceuticals Novel Drug Reconstitution System Product Table 78. Aerie Pharmaceuticals Recent Developments/Updates Table 79. Ionis Pharmaceuticals Corporation Information Table 80. Ionis Pharmaceuticals Description and Business Overview Table 81. Ionis Pharmaceuticals Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Ionis Pharmaceuticals Novel Drug Reconstitution System Product Table 83. Ionis Pharmaceuticals Recent Developments/Updates Table 84. Eisai Corporation Information Table 85. Eisai Description and Business Overview Table 86. Eisai Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 87. Eisai Novel Drug Reconstitution System Product Table 88. Eisai Recent Developments/Updates Table 89. Covis Pharma Corporation Information Table 90. Covis Pharma Description and Business Overview Table 91. Covis Pharma Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 92. Covis Pharma Novel Drug Reconstitution System Product Table 93. Covis Pharma Recent Developments/Updates Table 94. Allergan Corporation Information Table 95. Allergan Description and Business Overview Table 96. Allergan Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 97. Allergan Novel Drug Reconstitution System Product Table 98. Allergan Recent Developments/Updates Table 99. Gilead Sciences Corporation Information Table 100. Gilead Sciences Description and Business Overview Table 101. Gilead Sciences Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 102. Gilead Sciences Novel Drug Reconstitution System Product Table 103. Gilead Sciences Recent Developments/Updates Table 104. Bayer Healthcare Corporation Information Table 105. Bayer Healthcare Description and Business Overview Table 106. Bayer Healthcare Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 107. Bayer Healthcare Novel Drug Reconstitution System Product Table 108. Bayer Healthcare Recent Developments/Updates Table 109. Credence Medsystems Corporation Information Table 110. Credence Medsystems Description and Business Overview Table 111. Credence Medsystems Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 112. Credence Medsystems Novel Drug Reconstitution System Product Table 113. Credence Medsystems Recent Developments/Updates Table 114. Amgen Corporation Information Table 115. Amgen Description and Business Overview Table 116. Amgen Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 117. Amgen Novel Drug Reconstitution System Product Table 118. Amgen Recent Developments/Updates Table 119. Roche Corporation Information Table 120. Roche Description and Business Overview Table 121. Roche Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 122. Roche Novel Drug Reconstitution System Product Table 123. Roche Recent Developments/Updates Table 124. GlaxoSmithKline Corporation Information Table 125. GlaxoSmithKline Description and Business Overview Table 126. GlaxoSmithKline Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 127. GlaxoSmithKline Novel Drug Reconstitution System Product Table 128. GlaxoSmithKline Recent Developments/Updates Table 129. Vertex Pharmaceuticals Corporation Information Table 130. Vertex Pharmaceuticals Description and Business Overview Table 131. Vertex Pharmaceuticals Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 132. Vertex Pharmaceuticals Novel Drug Reconstitution System Product Table 133. Vertex Pharmaceuticals Recent Developments/Updates Table 134. Synergy Pharmaceuticals Corporation Information Table 135. Synergy Pharmaceuticals Description and Business Overview Table 136. Synergy Pharmaceuticals Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 137. Synergy Pharmaceuticals Novel Drug Reconstitution System Product Table 138. Synergy Pharmaceuticals Recent Developments/Updates Table 139. Otsuka Pharmaceutical Corporation Information Table 140. Otsuka Pharmaceutical Description and Business Overview Table 141. Otsuka Pharmaceutical Novel Drug Reconstitution System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 142. Otsuka Pharmaceutical Novel Drug Reconstitution System Product Table 143. Otsuka Pharmaceutical Recent Developments/Updates Table 144. Production Base and Market Concentration Rate of Raw Material Table 145. Key Suppliers of Raw Materials Table 146. Novel Drug Reconstitution System Distributors List Table 147. Novel Drug Reconstitution System Customers List Table 148. Novel Drug Reconstitution System Market Trends Table 149. Novel Drug Reconstitution System Market Drivers Table 150. Novel Drug Reconstitution System Market Challenges Table 151. Novel Drug Reconstitution System Market Restraints Table 152. Global Novel Drug Reconstitution System Sales Forecast by Type (2023-2028) & (K Units) Table 153. Global Novel Drug Reconstitution System Sales Market Share Forecast by Type (2023-2028) Table 154. Global Novel Drug Reconstitution System Revenue Forecast by Type (2023-2028) & (US$ Million) Table 155. Global Novel Drug Reconstitution System Revenue Market Share Forecast by Type (2023-2028) Table 156. Global Novel Drug Reconstitution System Sales Forecast by Application (2023-2028) & (K Units) Table 157. Global Novel Drug Reconstitution System Sales Market Share Forecast by Application (2023-2028) Table 158. Global Novel Drug Reconstitution System Revenue Forecast by Application (2023-2028) & (US$ Million) Table 159. Global Novel Drug Reconstitution System Revenue Market Share Forecast by Application (2023-2028) Table 160. Global Novel Drug Reconstitution System Sales Forecast by Region (2023-2028) & (K Units) Table 161. Global Novel Drug Reconstitution System Sales Market Share Forecast by Region (2023-2028) Table 162. Global Novel Drug Reconstitution System Revenue Forecast by Region (2023-2028) & (US$ Million) Table 163. Global Novel Drug Reconstitution System Revenue Market Share Forecast by Region (2023-2028) Table 164. Research Programs/Design for This Report Table 165. Key Data Information from Secondary Sources Table 166. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Novel Drug Reconstitution System Figure 2. Global Novel Drug Reconstitution System Market Share by Type in 2021 & 2028 Figure 3. Bottled Product Picture Figure 4. Bagged Product Picture Figure 5. Global Novel Drug Reconstitution System Market Share by Application in 2021 & 2028 Figure 6. Hospitals Figure 7. Clinics Figure 8. Others Figure 9. Global Novel Drug Reconstitution System Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Novel Drug Reconstitution System Market Size (2017-2028) & (US$ Million) Figure 11. Global Novel Drug Reconstitution System Sales (2017-2028) & (K Units) Figure 12. Novel Drug Reconstitution System Sales Share by Manufacturers in 2021 Figure 13. Global Novel Drug Reconstitution System Revenue Share by Manufacturers in 2021 Figure 14. The Global 5 and 10 Largest Novel Drug Reconstitution System Players: Market Share by Revenue in 2021 Figure 15. Novel Drug Reconstitution System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 16. Global Novel Drug Reconstitution System Sales Market Share by Region (2017-2022) Figure 17. Global Novel Drug Reconstitution System Sales Market Share by Region in 2021 Figure 18. Global Novel Drug Reconstitution System Revenue Market Share by Region (2017-2022) Figure 19. Global Novel Drug Reconstitution System Revenue Market Share by Region in 2021 Figure 20. United States Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Canada Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. U.K. Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. China Taiwan Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Mexico Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Brazil Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Argentina Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Colombia Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Turkey Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Saudi Arabia Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. UAE Novel Drug Reconstitution System Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Sales Market Share of Novel Drug Reconstitution System by Type (2017-2022) Figure 44. Manufacturing Cost Structure of Novel Drug Reconstitution System Figure 45. Manufacturing Process Analysis of Novel Drug Reconstitution System Figure 46. Novel Drug Reconstitution System Industrial Chain Analysis Figure 47. Channels of Distribution Figure 48. Distributors Profiles Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

3M Innovative Properties Baxter JW Group Pfizer Takeda Aerie Pharmaceuticals Ionis Pharmaceuticals Eisai Covis Pharma Allergan Gilead Sciences Bayer Healthcare Credence Medsystems Amgen Roche GlaxoSmithKline Vertex Pharmaceuticals Synergy Pharmaceuticals Otsuka Pharmaceutical